Former Walgreens could become five new retail suites - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 68%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

It's not the only former downtown drugstore getting creative in a down market.

The owner of a 10,200-square-foot former Walgreens at 740 Market St. has proposed converting the entirety of the space into as many as five retail suites, a potential creative adjustment to a difficult leasing environment downtown.

The conversion would seem to acknowledge the challenge of finding a tenant willing to take on the entirety of the space, which has been vacant since early March 2020. The Walgreens isn’t alone in proposing creative reconfigurations of former drugstore spaces downtown. Across the street from 740 Market St. is 731 Market St., one of six CVS stores that shuttered downtown earlier this year. Another occupying 8,638 square feet at 351 Market St. isFormer Walgreens spaces are being advertised for lease at 141 Kearny St. and 88 Spear St., as well as in the neighborhoods, at 2550 Ocean Ave.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 78. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Exelixis puts fat wallet to work with Cybrexa, Sairopa deals - San Francisco Business TimesPresident and CEO Michael Morrissey said the deals tap the company's balance sheet and share risks with its partners.
La source: SFBusinessTimes - 🏆 78. / 68 Lire la suite »

Gritstone Bio, other biotech companies are building drug pipelines with PIPEs - San Francisco Business TimesHow $GRTS and other public biotech companies are quietly raising chunks of capital from select investors PIPEs
La source: SFBusinessTimes - 🏆 78. / 68 Lire la suite »